F13B and nonpapillary renal cell carcinoma: Yang et al. [14] identified F13B as one of the prominently dysregulated proteins in the urine of clear cell renal cell carcinoma (ccRCC) patients, suggesting its potential significance in ccRCC diagnosis and prognosis, although it lacked statistical significance in the final analysis.